GARY W PACE
CIK 1184778 · last filed 2025-07-31
GARY W PACE is a corporate insider who has filed 81 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider bought $710.5K of CRDF on Jul 31, 2025. Across all open-market trades the lifetime net is −$19.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $51.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$51.72M
6
81
-$19.74M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRDF | Director | 2,676,352 | $1.54 | $4.12M | $2.94M | 17 | 2025-07-31 |
| PCRX | Director | 22,127 | $22.99 | $508.7K | -$5.22M | 25 | 2024-03-08 |
| Cardiff Oncology, Inc. (TROV) Delisted | Director | — | — | — | $0 | 1 | 2020-05-01 |
| RMD | Director | 241,736 | $194.78 | $47.09M | -$17.54M | 29 | 2018-05-10 |
| Imunon, Inc. (CLSN) Delisted | Director | 43,356 | $1.96 | $85.0K | $47.5K | 3 | 2010-02-23 |
| Imunon, Inc. (CLN) Delisted | Director | 20,349 | — | — | $37.4K | 4 | 2008-04-29 |
Recent Filings
81 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-31 | CRDF | Buy (P) | +290,000 | $710.5K | EDGAR |
| 2025-06-27 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2024-12-12 | CRDF | Buy (P) | +361,615 | $940.2K | EDGAR |
| 2024-07-01 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2024-03-08 | PCRX | Sell (S) | −119,323 | -$3.66M | EDGAR |
| 2023-12-19 | CRDF | Buy (P) | +30,000 | $41.1K | EDGAR |
| 2023-11-14 | CRDF | Buy (P) | +22,950 | $22.5K | EDGAR |
| 2023-06-20 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | PCRX | Grant (A) | +1,775 | $0 | EDGAR |
| 2023-05-15 | PCRX | Mixed | +1,985 | -$227 | EDGAR |